CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,431,111
- in 18 filings, $21.0M under 10b5-1 plans
Net −$21,431,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Quinlan Paul T −$2.6M General Counsel sold 49% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-14 | BRISTOW MICHAEL R Pres. & Chief Executive Offic | Grant or award · Stock Option (right to buy) | +95,000 | 95,000 | ||
| 2020-12-21 | BRISTOW MICHAEL R Pres. & Chief Executive Offic | Grant or award · Stock Option (right to buy) | +190,000 | 190,000 | ||
| 2017-04-04 | BRISTOW MICHAEL R Pres. & Chief Executive Offic | Sale | −720 | $2.41 | $2K | 41,155 |
| 2017-02-28 | BRISTOW MICHAEL R Pres. & Chief Executive Offic | Sale | −763 | $2.61 | $2K | 41,875 |
| 2017-02-27 | BRISTOW MICHAEL R Pres. & Chief Executive Offic | Grant or award · Stock Option (right to buy) | +41,600 | 41,600 | ||
| 2017-02-16 | BRISTOW MICHAEL R Pres. & Chief Executive Offic | Grant or award · Stock Option (right to buy) | +42,000 | 42,000 | ||
| 2016-09-20 | BRISTOW MICHAEL R Pres. & Chief Executive Offic | Sale | −1,972 | $2.89 | $6K | 42,638 |
| 2016-06-09 | BRISTOW MICHAEL R Pres. & Chief Executive Offic | Grant or award · Stock Option (right to buy) | +27,200 | 27,200 | ||
| 2016-06-09 | BRISTOW MICHAEL R Pres. & Chief Executive Offic | Grant or award · Stock Option (right to buy) | +55,400 | 55,400 | ||
| 2016-04-05 | BRISTOW MICHAEL R | Sale | −724 | $3.52 | $3K | 44,610 |
| 2016-03-01 | BRISTOW MICHAEL R | Sale | −752 | $3.50 | $3K | 45,334 |
| 2015-09-18 | BRISTOW MICHAEL R | Sale | −1,809 | $6.33 | $11K | 46,086 |
| 2015-03-02 | BRISTOW MICHAEL R | Sale | −5,446 | $0.71 | $4K | 335,279 |
| 2015-02-12 | BRISTOW MICHAEL R President and CEO | Grant or award | +48,100 | 340,725 | ||
| 2015-02-12 | BRISTOW MICHAEL R President and CEO | Grant or award · Stock Option (right to buy) | +25,900 | 25,900 | ||
| 2014-09-18 | BRISTOW MICHAEL R President and CEO | Sale | −13,853 | $1.30 | $18K | 292,625 |
| 2014-02-27 | BRISTOW MICHAEL R President and CEO | Grant or award | +56,700 | $1.95 | $111K | 306,478 |
| 2014-02-27 | BRISTOW MICHAEL R President and CEO | Grant or award · Stock Option (right to buy) | +51,500 | 51,500 | ||
| 2013-09-17 | BRISTOW MICHAEL R Pres & CEO | Grant or award | +125,000 | $1.38 | $173K | 249,778 |
| 2013-09-17 | BRISTOW MICHAEL R Pres & CEO | Grant or award · Stock Option (right to buy) | +282,825 | 282,825 |
Page 1 of 2 · 34 trades